SC
RMD icon

Schubert & Co’s ResMed RMD Stock Holding History

Schubert & Co’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29
Closed -$6.35K – 1196
2023
Q1 		$6.35K Sell
29
-2
-6% -$434 0.01% 360
2022
Q4 		$6.45K Sell
31
-2
-6% -$439 0.01% 334
2022
Q3 		$7K Buy
33
+7
+27% +$1.59K 0.01% 292
2022
Q2 		$5K Buy
26
+11
+73% +$2.34K ﹤0.01% 380
2022
Q1 		$4K Buy
15
+2
+15% +$484 ﹤0.01% 225
2021
Q4 		$3K Buy
+13
New +$3.37K ﹤0.01% 260

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schubert & Co's RMD Position: Q2 2023 in Review

Schubert & Co sold out of ResMed (RMD) in Q2 2023, closing a stake of 29 shares — an estimated $6.35K sold.

Schubert & Co first reported a position in RMD in Q4 2021 and held it in 6 quarters. The position peaked at $7K in Q3 2022. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

  • Schubert & Co reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 29 ResMed shares in Q2 2023, an estimated $6.35K.
  • Schubert & Co first reported a position in ResMed in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's ResMed position peaked at $7K in Q3 2022.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.